Skip to main content
ANTEROGEN CO., LTD. logo

ANTEROGEN CO., LTD. — Investor Relations & Filings

Ticker · 065660 ISIN · KR7065660003 KO Manufacturing
Open in API
Filings indexed 267 across all filing types
Latest filing 2024-03-08 Proxy Solicitation & In…
Country KR South Korea
Listing KO 065660

About ANTEROGEN CO., LTD.

http://anterogen.com

ANTEROGEN CO., LTD. is a bio-venture company engaged in the research, development, and commercialization of cell therapy products and orphan drugs. The company specializes in utilizing adult stem cells, particularly adipose-derived mesenchymal stem cells, to create innovative treatments. Its key commercialized products include Cupistem®, an autologous stem cell therapy for Crohn's fistula, and Queencell®. Anterogen's research pipeline extends to applications for musculoskeletal diseases, spinal injuries, and cardiovascular conditions. The company also offers stem cell banking services.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) issued by Anterogen. It includes details about the meeting date, location, agenda items (such as financial statement approval, director appointments, and remuneration limits), and information regarding electronic voting and management reports. This document is a formal proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and request their participation/votes. It fits the definition of a Proxy Solicitation & Information Statement (PSI).
2024-03-08 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (DART system) used to provide shareholders with information regarding upcoming general meetings, including agenda items, financial summaries, and proxy voting instructions. This falls under the 'Proxy Solicitation & Information Statement' category.
2024-03-08 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Anterogen Co., Ltd. It details the meeting date, location, agenda items (such as approval of financial statements, changes to articles of incorporation, and director compensation), and information regarding electronic voting. This document is a standard proxy solicitation material provided to shareholders to inform them of the upcoming Annual General Meeting (AGM) and to request their participation or proxy votes.
2024-03-04 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is the standard Korean regulatory filing for proxy solicitation. It contains details regarding the upcoming Annual General Meeting (AGM), including agenda items like approval of financial statements, articles of incorporation amendments, and director/auditor compensation limits. This document is specifically designed to solicit votes from shareholders for the meeting, fitting the definition of a Proxy Solicitation & Information Statement.
2024-03-04 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company cannot avoid the peak date for shareholder meetings due to internal audit and preparation schedules. This is a regulatory disclosure required by the exchange for transparency, fitting the 'Regulatory Filings' category as it does not constitute the meeting materials themselves, a proxy statement, or a report publication announcement.
2024-02-22 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Antrogen. It outlines the date, location, and agenda items (such as financial statement approval, articles of incorporation changes, and director/auditor compensation limits). This type of document is a standard proxy solicitation material sent to shareholders to inform them of an upcoming meeting and the items to be voted upon, which falls under the Proxy Solicitation & Information Statement category.
2024-02-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.